• Home
  • Search Results

Search Results

2474 studies match your search
Not currently enrolling

Device Testing Study for Adults with Depression

The purpose of this study is to test a brain stimulation device in Adults with Depression. We aim to make sure the device functions as designed and appropriately stores and transmits data.

Age & Gender
  • 18 years ~ 70 years
  • Male, Female, Gender Inclusive
Study Interest
  • Mental and Emotional Health
Open

First in Human Study of IMGN151 in adut patients with Recurrent Endometrial Cancer and Recurrent, High-Grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers.

Do you have Recurrent endometrial cancer,Recurrent, high-grade serous epithelial ovarian, primary peritoneal, or fallopian tube cancer that has progressed during or after standard treatments? If so, you may be able to take part in a research study looking at the safety of giving a treatment of test drug IMGN151-1001 to patients with these types of cancer

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial), Ovarian)
Not currently enrolling

Birth Experience and Stress Study

In this study, we want to see how giving birth affects stress chemicals in the body. We will focus on a stress hormone called cortisol and check its levels in people who gave birth, from 3 to 12 months after giving birth.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Women's Health
Visit Location
100% Remote (online, phone, text)
Open

Discrimination and Pregnancy Study

Are you 14 to 20 weeks pregnant with one baby? If so, you may be able to take part in a study on how stress and discrimination during pregnancy affect your health. We want to prevent high blood pressure and give better care to pregnant women.

Age & Gender
  • 18 years ~ 45 years
  • Female
Study Interest
  • Blood Pressure
  • Minority Health
  • Women's Health
  • and 2 more
Open

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission

Have you been diagnosed with aggressive B-cell lymphomas and received CAR-T treatment? If so, you may be able to take part in a research study. This study is looking at the efficacy of giving an investigational drug called Epcoritamab in comparison with no treatment. The participants should have received CAR-T treatment but did not have complete remission.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Glands and Hormones
Open

Venetoclax, MLN9708 and Dexamethasone for Relapsed or Refractory Light Chain Amyloidosis

Have you been diagnosed with relapsed or refractory light chain amyloidosis? If so, you may be able to take part in a research study looking at the safety and tolerability of giving Venetoclax, MLN9708 (ixazomib citrate) and Dexamethasone to patients with relapsed or refractory light chain amyloidosis.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Other Cancers)
Open

A PHASE 1/2A, OPEN-LABEL, DOSE-ESCALATION AND DOSE-EXPANSION FIRST-IN-HUMAN STUDY OF THE SAFETY, TOLERABILITY, ACTIVITY, AND PHARMACOKINETICS OF REGN10597 (ANTI PD-1-IL2RA-IL2 FUSION PROTEIN) IN PATIENTS WITH ADVANCED SOLID ORGAN MALIGNANCIES

Do you have kidney or bladder cancer. You may be able to participate in a research study to find out if the investigational drug REGN10597 is safe, tolerable, and effective in treating kidney and bladder cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Kidney)
Open

The ADD-Me Roster: a registry for those interested in brain health or Alzheimer's research

Do you have problems with your thinking or memory? Or a parent or sibling with dementia? If so, we'd like you to join this registry about the brain and Alzheimer's disease. In return for providing us with a little bit of your health history and background, we will connect you with researchers doing studies you can join, without obligation. Many studies pay a stipend and some offer a possible treatment.

Age & Gender
  • 45 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Brain, Head, Nervous System
  • Healthy Volunteer or General Population
Visit Location
100% Remote (online, phone, text)
Open

Teens, Emotions, and Social Interactions Study

Are you the parent of a female 13-15 year old teen? Do you have a history of depression? If so, you and your teen may be able to participate in a study looking at teenager's brain responses, emotions, social interactions, and depression risk. Families can be paid up to $375 for their participation in the study.

Age & Gender
  • 13 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • Healthy Volunteer or General Population
  • Parents of Children
Not currently enrolling

AI-assisted Deceptive Hotel Review Detection

The purpose of this research study is to investigate how human interpret some predictive learned by AI systems when detecting deceptive hotel reviews and how AI explanations can shape human understanding. For instance, the AI system learns that words like "floor" and "bathroom" are highly predictive of genuine reviews and words like "husband" and "luxury" are highly predictive of deceptive reviews. While the AI system highlights these words by learning from the data, the association between these words and the outcome are not easy to comprehend for humans. Thus, our goal of this research is to investigate how participants interact with machine-generated explanations that are unintuitive, and how participants make use of our developed visualizations and tools to make sense of these unintuitive features.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • UNC Students (undergrad, grad, professional)
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research